Becton Dickinson Current Ratio 2010-2022 | BDX

Current and historical current ratio for Becton Dickinson (BDX) from 2010 to 2022. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Becton Dickinson current ratio for the three months ending March 31, 2022 was 1.53.
Becton Dickinson Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2022-03-31 $10.15B $6.66B 1.53
2021-12-31 $8.31B $6.74B 1.23
2021-09-30 $8.84B $6.63B 1.33
2021-06-30 $9.54B $7.75B 1.23
2021-03-31 $10.00B $5.38B 1.86
2020-12-31 $9.54B $7.02B 1.36
2020-09-30 $8.97B $5.84B 1.54
2020-06-30 $8.83B $6.07B 1.46
2020-03-31 $8.56B $8.76B 0.98
2019-12-31 $6.44B $6.73B 0.96
2019-09-30 $6.66B $5.66B 1.18
2019-06-30 $6.78B $6.24B 1.09
2019-03-31 $6.84B $7.11B 0.96
2018-12-31 $6.94B $7.15B 0.97
2018-09-30 $7.41B $7.22B 1.03
2018-06-30 $7.53B $6.11B 1.23
2018-03-31 $7.51B $4.43B 1.70
2017-12-31 $7.54B $4.90B 1.54
2017-09-30 $18.63B $3.34B 5.58
2017-06-30 $18.21B $3.27B 5.56
2017-03-31 $4.89B $4.02B 1.22
2016-12-31 $5.19B $4.57B 1.14
2016-09-30 $6.37B $4.40B 1.45
2016-06-30 $6.53B $4.22B 1.55
2016-03-31 $6.61B $4.38B 1.51
2015-12-31 $5.64B $4.53B 1.25
2015-09-30 $5.66B $4.38B 1.29
2015-06-30 $6.30B $4.52B 1.40
2015-03-31 $7.00B $4.50B 1.56
2014-12-31 $12.11B $2.08B 5.82
2014-09-30 $6.13B $2.24B 2.74
2014-06-30 $6.05B $2.09B 2.89
2014-03-31 $5.95B $2.02B 2.95
2013-12-31 $5.74B $2.00B 2.88
2013-09-30 $5.87B $2.13B 2.76
2013-06-30 $5.44B $1.69B 3.21
2013-03-31 $5.50B $1.88B 2.93
2012-12-31 $5.48B $2.00B 2.73
2012-09-30 $5.32B $1.98B 2.69
2012-06-30 $5.29B $1.89B 2.80
2012-03-31 $5.30B $1.62B 3.27
2011-12-31 $5.69B $1.61B 3.55
2011-09-30 $4.67B $1.82B 2.56
2011-06-30 $5.07B $1.66B 3.06
2011-03-31 $4.86B $1.58B 3.08
2010-12-31 $4.95B $1.61B 3.07
2010-09-30 $4.51B $1.67B 2.70
2010-06-30 $4.12B $1.53B 2.69
2010-03-31 $3.94B $1.47B 2.69
2009-12-31 $4.06B $1.54B 2.64
2009-09-30 $4.65B $1.78B 2.62
2009-06-30 $4.49B $1.65B 2.73
2009-03-31 $3.41B $1.51B 2.26
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $69.707B $20.248B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $46.168B 13.57
AmerisourceBergen (ABC) United States $29.993B 13.84
West Pharmaceutical Services (WST) United States $21.960B 33.46
Laboratory Of America Holdings (LH) United States $21.873B 9.14
Cooper (COO) United States $15.496B 23.85
Cardinal Health (CAH) United States $14.662B 11.26
CONMED (CNMD) United States $2.878B 29.72
Invacare (IVC) United States $0.053B 0.00